Goldman Sachs

INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Investigates The Goldman Sachs Group, Inc.’s Directors and Officers for Breach of Fiduciary Duties – GS

Retrieved on: 
Wednesday, June 7, 2023
Class Action Lawsuit, Professional Services, Legal, Goldman Sachs Group, Inc. v. Arkansas Teacher Retirement System, GS, Law, Goldman Sachs, Woman, Bias, Goldman, NYSE, Holding company, Security (finance)

Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, continues to investigate whether certain directors and officers of The Goldman Sachs Group, Inc. (“Goldman Sachs”) (NYSE: GS) breached their fiduciary duties to Goldman Sachs and its shareholders.

Key Points: 
  • Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, continues to investigate whether certain directors and officers of The Goldman Sachs Group, Inc. (“Goldman Sachs”) (NYSE: GS) breached their fiduciary duties to Goldman Sachs and its shareholders.
  • If you are a Goldman Sachs shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982, or [email protected] .
  • Scott+Scott is investigating whether members of Goldman Sachs’s board of directors or senior management failed to manage Goldman Sachs in an acceptable manner, in breach of their fiduciary duties to Goldman Sachs, and whether Goldman Sachs and its shareholders have suffered damages as a result.
  • If you are a Goldman Sachs shareholder, you may have legal claims against Goldman Sachs’s directors and officers.

Geron to Participate in Goldman Sachs 44th Annual Global Healthcare Conference

Retrieved on: 
Wednesday, June 7, 2023
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, Goldman Sachs, Webcast, Corporation, Goldman, Geron Corporation, Conference, Event, Pharmaceutical industry, Broadcasting

Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to participate in a fireside chat in person at the Goldman Sachs 44th Annual Global Healthcare Conference in Dana Point, CA, on Thursday, June 15, 2023 at 8:40 a.m. PT.

Key Points: 
  • Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to participate in a fireside chat in person at the Goldman Sachs 44th Annual Global Healthcare Conference in Dana Point, CA, on Thursday, June 15, 2023 at 8:40 a.m. PT.
  • A webcast of the presentation will be available through the Investor Relations section of Geron’s website under Events .
  • Following the presentation, the webcast will be archived and available for replay for a period of 30 days.

2seventy bio to Participate in Upcoming Investor Conference

Retrieved on: 
Wednesday, June 7, 2023
Biotechnology, General Health, Health, Genetics, Oncology, Goldman Sachs, Goldman, Conference, Pharmaceutical industry, Online shopping

2seventy bio, Inc .

Key Points: 
  • 2seventy bio, Inc .
  • (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, announced today that members of the management team will participate in a fireside chat at the upcoming Goldman Sachs 44th Annual Global Healthcare Conference on Wednesday, June 14, 2023 at 6:20pm ET in Dana Point, CA.
  • A live webcast will be available via the Investors and Media section of 2seventy bio’s website at https://ir.2seventybio.com/ .
  • A replay will be archived on 2seventy bio’s site for 30 days following the event.

Digibee Receives $60 Million Series B Funding to Continue Focusing on Growth and Expansion in the US and on Further Success in Latin America

Retrieved on: 
Wednesday, June 7, 2023
Software, Technology, Internet, Data Management, Partnership, Agility, Venture round, Goldman Sachs, CVC, Organization, Improper integral, Growth capital, Security (finance), Series

Digibee , an integration platform as a service (iPaaS) company that helps organizations build flexible, highly scalable integration architecture, today announced it received $60 million in Series B funding.

Key Points: 
  • Digibee , an integration platform as a service (iPaaS) company that helps organizations build flexible, highly scalable integration architecture, today announced it received $60 million in Series B funding.
  • The Series B round follows a $25 million Series A round led by Softbank Latin America Fund (later renamed to Upload Ventures) and announced in February 2022 and a $6 million seed investment in February 2019.
  • Digibee will use the Series B funding for product enhancements, expansion of go-to-market initiatives, customer support in the U.S. and for support of its ongoing success in Latin America.
  • The Series B round will help Digibee advance its mission of revolutionizing the way IT delivers business value with modern integration technology.

Marketing Titan Launches The Avenue Z Network

Retrieved on: 
Wednesday, June 7, 2023
Media, Social Media, Search Engine Optimization, Search Engine Marketing, Influencer, Other Communications, Digital Marketing, Public Relations, Investor Relations, Marketing, Advertising, Communications, Content Marketing, DTC, OAK, General partner, RRE Ventures, Social media, Goldman Sachs, Oak Investment Partners, Newgate, Acquisition, Mergers and acquisitions, Hearst Communications, Digital, ROI, Avenue, Environment, Adweek, Data science, Video game

Digital visionary Jeffrey Herzog today announced the launch of the Avenue Z Network , a new strategic communications consultancy.

Key Points: 
  • Digital visionary Jeffrey Herzog today announced the launch of the Avenue Z Network , a new strategic communications consultancy.
  • Avenue Z will build and scale the next generation of integrated communications with public relations and digital media solutions for growth-driven brands.
  • “Avenue Z will bring together the world’s most talented publicists, content creators, media buyers, marketers and data analysts to craft narratives that move the needle for business growth.
  • Avenue Z is funded by Herzog and Baleon Capital, a private equity fund focused on B2B tech-enabled services.

Fairway Private Equity & Venture Capital Opportunities Fund Announces First Quarter Results

Retrieved on: 
Wednesday, June 7, 2023
Personal Finance, Legal, Insurance, Finance, Consulting, Banking, Accounting, Professional Services, Asset Management, Other Professional Services, Private equity, GCM Grosvenor, Interview, DLJ, Investment, TD, Net asset value, Adage Capital Management, TD Securities, Wall Street, Investment Company Act of 1940, Goldman Sachs, Boeing, Acquisition, Partner, Corporation, Partnership, KPMG, Merrill (company), Financial analyst, Fund, Cryptocurrency, Security (finance), Financial adviser, Fairway

Fairway Capital Management (“Fairway”), an investment management firm founded by a team of five colleagues that formerly worked together at Adams Street Partners, announced today that Fairway Private Equity & Venture Capital Opportunities Fund (the “Fund”) increased in Net Asset Value by 4.09% in the quarter ended March 31, 2023.

Key Points: 
  • Fairway Capital Management (“Fairway”), an investment management firm founded by a team of five colleagues that formerly worked together at Adams Street Partners, announced today that Fairway Private Equity & Venture Capital Opportunities Fund (the “Fund”) increased in Net Asset Value by 4.09% in the quarter ended March 31, 2023.
  • As a ’40 Act fund, Fairway Private Equity & Venture Capital Opportunities Fund offers greater flexibility than a traditional, institutionally oriented private equity investment vehicle.
  • The evergreen structure provides immediate and continuous exposure to high-quality private equity and venture capital investments.
  • The Fairway team includes veteran private equity professionals with total collective experience of 100+ years and deep relationships with many leading private equity and venture capital General Partners.

Reata Pharmaceuticals Announces Participation in the Goldman Sachs 44th Annual Global Healthcare Conference

Retrieved on: 
Tuesday, June 6, 2023
Biotechnology, General Health, Pharmaceutical, Health, Medication, Reata Pharmaceuticals, Goldman Sachs, Goldman, Patient, Conference, Pharmaceutical industry

Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a global biopharmaceutical company focused on developing and commercializing novel therapies for patients with severe diseases, announced that management will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on June 12 – 15, 2023, in Dana Point, California.

Key Points: 
  • Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a global biopharmaceutical company focused on developing and commercializing novel therapies for patients with severe diseases, announced that management will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on June 12 – 15, 2023, in Dana Point, California.
  • Manmeet Soni, Reata’s President, Chief Operating Officer, and Chief Financial Officer will be participating in a fireside chat during the conference.

Natera to Participate in Goldman Sachs 44th Annual Global Healthcare Conference

Retrieved on: 
Tuesday, June 6, 2023
Biotechnology, Health, Genetics, Health Technology, Oncology, Goldman Sachs, DNA, Goldman, Conference, NTRA, Mobile phone, Broadcasting, Natera

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that members of its management team will present at the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13 at 5:40 pm ET | 2:40 pm PT in Dana Point, CA.

Key Points: 
  • Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that members of its management team will present at the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13 at 5:40 pm ET | 2:40 pm PT in Dana Point, CA.
  • A live webcast and audio archive of the event may be accessed through the investor relations section of the Natera website at investor.natera.com .
  • A replay of the event will be available shortly following the conference.

Arrowhead Pharmaceuticals to Participate in Upcoming June 2023 Conferences

Retrieved on: 
Tuesday, June 6, 2023
Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Genetics, Clinical Trials, Arrowhead, EASL, Goldman, Liver disease, Goldman Sachs, Congress, European Association for the Study of the Liver, Conference, Pharmaceutical industry, Dietary supplement, Liver

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:

Key Points: 
  • Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:
    Jefferies Global Healthcare Conference – June 8, 2023
    Goldman Sachs 44th Annual Global Healthcare Conference – June 12, 2023
    European Association for the Study of the Liver (EASL) Congress 2023 – June 24, 2023
    Title: Fazirsiran reduces liver Z-alpha-1 antitrypsin synthesis, decreases globule burden and improves histological measures of liver disease in adults with alpha-1 antitrypsin deficiency: a randomized placebo-controlled phase 2 study
    Webcast links and presentation materials may be accessed on the Events and Presentations page under the Investors section of the Arrowhead website.

Crow Holdings Launches Renewables Business to Capitalize on Strong Nationwide Demand

Retrieved on: 
Tuesday, June 6, 2023
Alternative Energy, Energy, Professional Services, Finance, EDP Renováveis, NextEra Energy Resources, Holding, Morgan Stanley, Senior, Wind, Pelosi, Crow Holdings, Goldman Sachs, EDP, Renewable energy, Lennar

Crow Holdings, a leading national real estate investment and development firm, announced today the launch of Crow Holdings Renewables, a new business that aims to apply Crow Holdings’ development expertise and local presence in several of the fastest-growing solar markets across the U.S. to develop community- and utility-scale solar energy and battery storage projects across the country.

Key Points: 
  • Crow Holdings, a leading national real estate investment and development firm, announced today the launch of Crow Holdings Renewables, a new business that aims to apply Crow Holdings’ development expertise and local presence in several of the fastest-growing solar markets across the U.S. to develop community- and utility-scale solar energy and battery storage projects across the country.
  • Crow Holdings Renewables is initially focused on the entitlement and development of community solar projects (and related battery storage solutions) averaging 5 Megawatts (MW) and mid-sized, utility-scale projects averaging 25 MW.
  • As a business line of Crow Holdings, which has significant greenfield development experience, Crow Holdings Renewables is also well-positioned to leverage an extensive portfolio of industrial properties, with potential to add solar to millions of square feet of industrial rooftops across the country that could provide lower-cost energy to all ratepayers.
  • Crow Holdings Renewables is co-led by Laurence Pelosi, Senior Managing Director at Crow Holdings, and Tim Marvich, who recently joined the company as a Managing Director.